Drugs / SAR446959
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06704932 | Nov 2024 → Dec 2025 | osteoarthritis | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR446959 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06704932 ↗ |
| Route | Other | “Route of administration:Intra-articular injection” NCT06704932 ↗ |